Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Investing Activities (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Cash from Investing Activities data on record, last reported at $17.0 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 163.59% year-over-year to $17.0 million; the TTM value through Sep 2025 reached $136.4 million, up 453.79%, while the annual FY2024 figure was $29.0 million, 126.15% up from the prior year.
  • Cash from Investing Activities reached $17.0 million in Q3 2025 per GOSS's latest filing, down from $44.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $61.7 million in Q1 2024 and bottomed at -$118.3 million in Q3 2023.
  • Average Cash from Investing Activities over 4 years is $14666.7, with a median of $8.5 million recorded in 2022.
  • The widest YoY moves for Cash from Investing Activities: up 607.1% in 2024, down 556.96% in 2024.
  • A 4-year view of Cash from Investing Activities shows it stood at $8.5 million in 2022, then plummeted by 269.73% to -$14.4 million in 2023, then soared by 470.43% to $53.2 million in 2024, then crashed by 68.03% to $17.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $17.0 million in Q3 2025, $44.1 million in Q2 2025, and $22.1 million in Q1 2025.